Find, compare & contact
Montelukastum (Montelukast) API Manufacturers & Suppliers

Looking for Montelukast API 158966-92-8?

Description:

Here you will find a list of producers, manufacturers and distributors of Montelukast. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Montelukast 

Synonyms:

Montelukast , Montelukastum , Montelukast sodium  

Cas Number:

158966-92-8 

DrugBank number:

DB00471 

Unique Ingredient Identifier:

MHM278SD3E

Montelukast is a type of Leukotriene antagonists

Leukotriene antagonists, a subcategory of pharmaceutical active pharmaceutical ingredients (APIs), are widely used in the treatment of inflammatory conditions, particularly in respiratory disorders such as asthma. These antagonists work by inhibiting the action of leukotrienes, which are inflammatory mediators released by immune cells.

Leukotrienes play a crucial role in promoting inflammation, bronchoconstriction, and mucus production in the airways. By targeting and blocking the receptors for leukotrienes, antagonists can effectively reduce the inflammatory response and alleviate symptoms associated with asthma and other respiratory conditions.

Montelukast, zafirlukast, and pranlukast are among the most commonly prescribed leukotriene antagonists. These APIs are typically formulated into oral tablets or granules for ease of administration. They are generally well-tolerated and exhibit a favorable safety profile.

Leukotriene antagonists are often used as part of a comprehensive treatment plan for asthma management, either as a monotherapy or in combination with other medications like inhaled corticosteroids. They provide a valuable alternative for patients who may have difficulty using inhalers or require additional control of their symptoms.

In conclusion, leukotriene antagonists are an important class of pharmaceutical APIs used in the treatment of inflammatory conditions, particularly asthma. By inhibiting the action of leukotrienes, these agents effectively reduce inflammation and alleviate respiratory symptoms. Their use as part of a comprehensive treatment approach can significantly improve the quality of life for patients suffering from asthma and other related respiratory disorders.

Montelukast (Leukotriene antagonists), classified under Respiratory Tract Agents

Respiratory Tract Agents are a vital category of pharmaceutical APIs (Active Pharmaceutical Ingredients) designed to treat respiratory conditions and diseases. These agents are specifically formulated to target the respiratory system, which includes the lungs, airways, and nasal passages. They play a crucial role in managing various respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis.

Respiratory Tract Agents encompass a wide range of medications, including bronchodilators, corticosteroids, antihistamines, and mucolytics. Bronchodilators are commonly used to relieve airway constriction and facilitate smooth breathing by relaxing the muscles in the airways. Corticosteroids help reduce inflammation in the respiratory system, alleviating symptoms and preventing exacerbations. Antihistamines work by blocking histamine receptors, thus mitigating allergic reactions that often impact the respiratory tract. Mucolytics aid in loosening and thinning mucus, making it easier to expel from the airways.

These APIs are developed through rigorous research and development processes, ensuring their efficacy, safety, and compliance with regulatory standards. Pharmaceutical manufacturers rely on advanced technologies and stringent quality control measures to produce high-quality Respiratory Tract Agents. These APIs are subsequently incorporated into various dosage forms, including inhalers, nasal sprays, nebulizers, and oral medications.

Respiratory Tract Agents are essential in the management of respiratory conditions, providing relief from symptoms, improving lung function, and enhancing the overall quality of life for patients. They are prescribed by healthcare professionals and often used in combination therapies to achieve optimal results. As respiratory disorders continue to affect a significant portion of the global population, the development and availability of effective Respiratory Tract Agents play a vital role in addressing these health challenges and improving patient outcomes.

• Morepen Laboratories Ltd. from India, product country of origin India
• Xi'an ZB Biotech Co., Ltd from China, product country of origin China
• LGM Pharma from United States, product country of origin World
• SETV Global from India, product country of origin India
• Shandong Octagon Chemicals Limited from China, product country of origin China
• AXXO GmbH from Germany, product country of origin World
• Vamsi Labs from India, product country of origin India
• Qilu Tianhe from China, product country of origin China
• TIEFENBACHER API + Ingredients from Germany, product country of origin Unknown
• Unichem Labs. from India, product country of origin India
• Solfyn International LLP from India, product country of origin India
• Unnati Pharmaceuticals Pvt Ltd from India, product country of origin India
• Zhejiang Tianyu from China, product country of origin China
• Laurus Labs from India, product country of origin India
• Teva API from Israel, product country of origin Unknown
• Formosa Labs from Taiwan, product country of origin Taiwan
• Miat from Italy, product country of origin Italy
• Sintenovo from Spain, product country of origin Spain
• Triquim from Argentina, product country of origin Argentina
• Unimark Remedies from India, product country of origin India
• Flavine from Germany, product country of origin Unknown
• Dr. Reddy's from India, product country of origin India
• JW Pharmaceutical from South Korea, product country of origin South Korea
• Torrent Pharma from India, product country of origin India
• Hwail Pharm from South Korea, product country of origin South Korea
• Mylan from India, product country of origin India
• Cipla from India, product country of origin India
• Hetero Drugs from India, product country of origin Unknown
• MSN Pharma from India, product country of origin India
• Sun Pharma from India, product country of origin India
• Teva Pharma ind. from Israel, product country of origin India
• Shaoxing Hantai Pharma from China, product country of origin China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.